CHF 162.88
(3.52%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 10.34 CHF | 8.5% |
2022 | 9.53 CHF | -4.22% |
2021 | 9.95 CHF | 14.5% |
2020 | 8.69 CHF | 40.61% |
2019 | 6.18 CHF | 2.66% |
2018 | 6.02 CHF | 6.17% |
2017 | 5.67 CHF | 19.62% |
2016 | 4.74 CHF | -6.14% |
2015 | 5.05 CHF | 39.12% |
2014 | 3.63 CHF | -12.74% |
2013 | 4.16 CHF | 6.12% |
2012 | 3.92 CHF | -11.31% |
2011 | 4.42 CHF | 185.16% |
2010 | 1.55 CHF | -67.51% |
2009 | 4.77 CHF | 102.98% |
2008 | 2.35 CHF | -48.24% |
2007 | 4.54 CHF | 28.25% |
2006 | 3.54 CHF | 180.95% |
2005 | 1.26 CHF | 8.62% |
2004 | 1.16 CHF | -4.13% |
2003 | 1.21 CHF | -53.1% |
2002 | 2.58 CHF | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 1.76 CHF | 0.0% |
2023 Q2 | 4.17 CHF | 0.0% |
2023 FY | - CHF | 8.5% |
2023 Q4 | 6.17 CHF | 0.0% |
2022 FY | - CHF | -4.22% |
2022 Q2 | 5.17 CHF | 0.0% |
2022 Q4 | 4.36 CHF | 0.0% |
2021 Q2 | 6.88 CHF | 0.0% |
2021 Q4 | 3.08 CHF | 0.0% |
2021 FY | - CHF | 14.5% |
2020 Q4 | 5.66 CHF | 0.0% |
2020 FY | - CHF | 40.61% |
2020 Q2 | 3.02 CHF | 0.0% |
2019 Q2 | 2.14 CHF | 0.0% |
2019 FY | - CHF | 2.66% |
2019 Q4 | 4.03 CHF | 0.0% |
2018 Q2 | 2.46 CHF | 0.0% |
2018 Q4 | 3.50 CHF | 0.0% |
2018 FY | - CHF | 6.17% |
2017 Q2 | 2.22 CHF | 0.0% |
2017 Q4 | 3.36 CHF | 0.0% |
2017 FY | - CHF | 19.62% |
2016 Q4 | 2.66 CHF | 0.0% |
2016 FY | - CHF | -6.14% |
2016 Q2 | 2.00 CHF | 0.0% |
2015 Q2 | 2.23 CHF | 0.0% |
2015 FY | - CHF | 39.12% |
2015 Q4 | 2.73 CHF | 0.0% |
2014 FY | - CHF | -12.74% |
2014 Q2 | 1.65 CHF | 0.0% |
2014 Q4 | 1.92 CHF | 0.0% |
2013 Q2 | 1.49 CHF | 0.0% |
2013 FY | - CHF | 6.12% |
2013 Q4 | 2.61 CHF | 0.0% |
2012 Q1 | 0.96 CHF | 0.0% |
2012 Q4 | 1.03 CHF | 7.29% |
2012 Q3 | 0.96 CHF | 0.0% |
2012 Q2 | 0.96 CHF | 0.0% |
2012 FY | - CHF | -11.31% |
2011 Q3 | 1.03 CHF | 0.0% |
2011 FY | - CHF | 185.16% |
2011 Q1 | 1.03 CHF | 0.0% |
2011 Q2 | 1.03 CHF | 0.0% |
2011 Q4 | 0.96 CHF | -6.8% |
2010 Q3 | 1.11 CHF | 0.0% |
2010 FY | - CHF | -67.51% |
2010 Q1 | 1.11 CHF | 0.0% |
2010 Q2 | 1.11 CHF | 0.0% |
2010 Q4 | 1.03 CHF | -7.21% |
2009 Q2 | 1.12 CHF | 0.0% |
2009 FY | - CHF | 102.98% |
2009 Q1 | 1.12 CHF | 0.0% |
2009 Q3 | 1.12 CHF | 0.0% |
2009 Q4 | 1.11 CHF | -0.89% |
2008 FY | - CHF | -48.24% |
2008 Q1 | 0.58 CHF | 0.0% |
2008 Q2 | 0.58 CHF | 0.0% |
2008 Q3 | 0.58 CHF | 0.0% |
2008 Q4 | 1.12 CHF | 93.1% |
2007 Q1 | 1.13 CHF | 0.0% |
2007 Q4 | 0.58 CHF | -48.67% |
2007 Q3 | 1.13 CHF | 0.0% |
2007 Q2 | 1.13 CHF | 0.0% |
2007 FY | - CHF | 28.25% |
2006 Q2 | 0.88 CHF | 0.0% |
2006 Q3 | 0.88 CHF | 0.0% |
2006 FY | - CHF | 180.95% |
2006 Q4 | 1.13 CHF | 28.41% |
2006 Q1 | 0.88 CHF | 0.0% |
2005 Q4 | 0.88 CHF | 175.0% |
2005 FY | - CHF | 8.62% |
2005 Q1 | 0.32 CHF | 0.0% |
2005 Q2 | 0.32 CHF | 0.0% |
2005 Q3 | 0.32 CHF | 0.0% |
2004 FY | - CHF | -4.13% |
2004 Q4 | 0.32 CHF | 10.34% |
2004 Q1 | 0.29 CHF | 0.0% |
2004 Q2 | 0.29 CHF | 0.0% |
2004 Q3 | 0.29 CHF | 0.0% |
2003 Q2 | 0.30 CHF | 0.0% |
2003 Q4 | 0.29 CHF | -3.33% |
2003 Q3 | 0.30 CHF | 0.0% |
2003 FY | - CHF | -53.1% |
2003 Q1 | 0.30 CHF | 0.0% |
2002 Q4 | 0.30 CHF | -53.13% |
2002 Q2 | 0.64 CHF | 0.0% |
2002 Q1 | 0.64 CHF | 0.0% |
2002 FY | - CHF | 0.0% |
2002 Q3 | 0.64 CHF | 0.0% |
2001 Q4 | 0.64 CHF | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Relief Therapeutics Holding AG | -8.35 CHF | 223.832% |
Santhera Pharmaceuticals Holding AG | 5.18 CHF | -99.614% |
Basilea Pharmaceutica AG | 0.87 CHF | -1088.506% |
Bachem Holding AG | 1.50 CHF | -589.333% |
Siegfried Holding AG | 26.61 CHF | 61.142% |
Molecular Partners AG | -1.89 CHF | 647.09% |